商之器

-0.10 (-0.55%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

18.102成交張數17.75本益比1.93股價淨值比0.00%殖利率2026-09-11資料日期

毛利率、營業利益率、淨利率

單季;近十年

單季營收

億元

季度	營收(億)	營收年增	毛利(億)	毛利率	營業利益(億)	營業利益率	淨利率
2026Q2	0.4	6.8%	0.3	73.1%	-0.2	-56.0%	-51.9%
2026Q1	0.5	121.8%	0.4	80.3%	-0.0	-8.5%	-3.0%
2025Q4	0.8	-53.5%	0.7	82.2%	0.3	37.6%	31.8%
2025Q3	1.1	135.7%	0.7	60.5%	0.3	22.6%	23.2%
2025Q2	0.3	20.4%	0.2	70.1%	-0.2	-53.7%	-59.6%
2025Q1	0.2	-13.5%	0.1	61.3%	-0.3	-124.4%	-107.3%
2024Q4	1.8	82.9%	1.0	58.8%	0.7	38.6%	36.4%
2024Q3	0.5	10.8%	0.4	80.8%	-0.1	-24.6%	-18.5%
2024Q2	0.3	-18.2%	0.2	60.5%	-0.3	-105.0%	-114.2%
2024Q1	0.3	-14.1%	0.2	65.4%	-0.2	-90.9%	-81.5%
2023Q4	1.0	-0.5%	0.8	79.8%	0.4	36.2%	33.6%
2023Q3	0.4	9.7%	0.3	72.9%	-0.1	-24.0%	-31.6%
2023Q2	0.3	-1.1%	0.2	71.2%	-0.2	-50.8%	-43.7%
2023Q1	0.3	-85.2%	0.2	68.8%	-0.2	-69.1%	-57.9%
2022Q4	1.0	13.4%	0.6	59.6%	0.1	9.9%	11.5%
2022Q3	0.4	-16.2%	0.3	71.6%	-0.1	-36.4%	-32.4%
2022Q2	0.3	2.4%	0.2	66.2%	-0.2	-61.7%	-63.8%
2022Q1	2.1	662.3%	0.7	35.3%	0.3	14.9%	13.0%
2021Q4	0.9	12.1%	0.6	71.1%	0.2	22.3%	25.1%
2021Q3	0.5	9.9%	0.3	67.5%	-0.1	-22.1%	-19.7%
2021Q2	0.3	12.1%	0.2	71.5%	-0.2	-51.1%	-54.0%
2021Q1	0.3	-57.5%	0.1	51.4%	-0.3	-97.3%	-57.8%
2020Q4	0.8	-29.8%	0.6	72.4%	0.2	22.9%	22.9%
2020Q3	0.4	34.0%	0.3	74.7%	-0.1	-28.5%	-17.7%
2020Q2	0.3	-35.1%	0.2	64.2%	-0.3	-97.7%	-93.0%
2020Q1	0.7	40.0%	0.4	58.3%	-0.1	-21.1%	-18.9%
2019Q4	1.1	13.9%	0.8	71.6%	0.3	23.3%	25.2%
2019Q3	0.3	-9.9%	0.2	72.4%	-0.2	-67.8%	-73.7%
2019Q2	0.5	12.1%	0.3	73.6%	-0.1	-15.6%	-15.6%
2019Q1	0.5	23.3%	0.4	80.2%	-0.1	-24.0%	-23.9%
2018Q4	1.0	44.0%	0.8	81.8%	0.3	29.1%	27.7%
2018Q3	0.4	-19.3%	0.3	77.7%	-0.2	-49.4%	-52.2%
2018Q2	0.4	1.5%	0.3	75.9%	-0.1	-30.5%	-25.9%
2018Q1	0.4	-23.7%	0.3	70.2%	-0.2	-40.7%	-20.9%
2017Q4	0.7	-38.6%	0.5	68.9%	0.0	0.5%	8.7%
2017Q3	0.4	-27.1%	0.3	68.3%	-0.1	-32.1%	-35.4%
2017Q2	0.4	-27.1%	0.2	58.4%	-0.2	-44.2%	-44.4%
2017Q1	0.5	66.3%	0.3	53.9%	-0.1	-25.2%	-29.3%
2016Q4	1.1	–	0.6	52.8%	0.1	9.9%	3.7%
2016Q3	0.6	–	0.3	52.1%	-0.1	-21.3%	-21.1%